Table 1.
Hormonal concentrations at baseline and 7 days after a single subcutaneous dose of human chorionic gonadotropin (rhCG, Ovidrel® 250 mcg)
| Hormones | Basal | After rhCG (7 days) |
|---|---|---|
| mean (SD) | mean (SD) | |
| Testosterone (ng/dl) | 10.0 (0) | 247.8 (135.8) |
| DHT (ng/dl) | 4.6 (0.8) | 32.3 (18.0) |
| T/DHT | 2.2 (0.4) | 8.0 (3.5) |
| Inhibin B (pg/ml) | 105.8 (65.2) | 132.4 (56.1) |
| AMH (ng/ml) | 109.4 (52.6) | 152.9 (65.2) |
| Androstenedione (ng/ml) | 0.2 (0.4) | 0.3 (0.2) |
| 17OHP (ng/ml) | 0.4 (0.3) | 0.7 (0.4) |
| FSH (IU/L) | 0.6 (0.4) | 0.2 (0.1) |
| LH (IU/L) | 0.1 (0.1) | 0.1 (0.2) |
| Beta hCG (IU/L) | - | 15.8 (10.2) |
hCG human chorionic gonadotropin, rhCG recombinant human chorionic gonadotropin, DHT dihydrotestosterone hormone, T/DHT Testosterone/DHT ratio, AMH Anti-Mullerian hormone, 17OHP 17-hidroxi-progesterone hormone, FSH Follicle stimulanting hormone, LH Luteinizing hormone, SD standard deviation